Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/1999
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013076A1 Mpl ligand analogs
03/18/1999WO1999013066A1 Secreted proteins and polynucleotides encoding them
03/18/1999WO1999012971A2 Amino acid sequences for therapeutical and prophylactic applications to diseases due to clostridium difficile toxins
03/18/1999WO1999012969A1 Treatment of obesity
03/18/1999WO1999012965A2 April- a novel protein with growth effects
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012936A1 Furopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012935A1 Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
03/18/1999WO1999012934A1 Pyrrolopyrrolone derivatives
03/18/1999WO1999012933A2 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012932A1 Method of inhibiting serine protease enzymes
03/18/1999WO1999012931A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999WO1999012916A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/18/1999WO1999012908A1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity
03/18/1999WO1999012905A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999WO1999012901A1 Substituted 2-pyrrolidinone activators of pkc
03/18/1999WO1999012898A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
03/18/1999WO1999012896A1 Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists
03/18/1999WO1999012894A1 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
03/18/1999WO1999012574A1 Improvements in or relating to expression of immunogenic substances
03/18/1999WO1999012573A1 Improvements in or relating to regulation of t cell activation
03/18/1999WO1999012567A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999WO1999012561A2 FRACTURE HEALING USING PTHrP ANALOGS
03/18/1999WO1999012560A1 Synergistic effects of op/bmp morphogens and gdnf/ngf neurotrophic factors
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012551A1 Method of increasing bone volume using non-naturally-occurring fp selective agonists
03/18/1999WO1999012522A1 High and low load formulations of igf-i in multivesicular liposomes
03/18/1999WO1999012431A1 Animal feed containing carboxylic acids
03/18/1999WO1999000140A3 Accelerating animal hoof growth with somatotropin
03/18/1999WO1998055510A3 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
03/18/1999WO1998052614A3 Composition and method for enhancing transport across biological membranes
03/18/1999DE19737224A1 Pharmaceutical preparation for cardiovascular treatment
03/18/1999CA2569685A1 Indolecarboxylic compounds and their use as pharmaceutical compounds
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303800A1 Method of increasing bone volume using non-naturally-occurring fp selective agonists
03/18/1999CA2303618A1 Improvements in or relating to expression of immunogenic substances
03/18/1999CA2303617A1 Improvements in or relating to regulation of t cell activation
03/18/1999CA2303615A1 April- a novel protein with growth effects
03/18/1999CA2303480A1 Mpl ligand analogs
03/18/1999CA2303424A1 Kay - a novel immune system protein
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2303249A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303248A1 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs
03/18/1999CA2303176A1 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
03/18/1999CA2303146A1 Substituted 2-pyrrolidinone activators of pkc
03/18/1999CA2302705A1 Secreted proteins and polynucleotides encoding them
03/18/1999CA2301979A1 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor
03/18/1999CA2296358A1 Certain benzothiazine dioxide endothelin antagonists and processes for their preparation
03/17/1999EP0902085A1 Recombinant human erythropoietin with advantageous glycosylation profile
03/17/1999EP0902027A1 Indole and indazole derivatives, process for their preparation and the pharmaceutical compositions containing them
03/17/1999EP0902022A1 Novel benzofuranone derivatives and process for producing the same
03/17/1999EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives
03/17/1999EP0901788A2 Use of inhibitors of the sodium hydrogen exchange in the manufacture of a medicament
03/17/1999EP0901786A2 Solid pharmaceutical dispersions with enhanced bioavailability
03/17/1999EP0901487A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
03/17/1999EP0901471A1 Antagonists of gonadotropin releasing hormone
03/17/1999EP0901470A1 Indole derivatives useful as endothelin receptor antagonists
03/17/1999EP0901469A1 Arylalkylpiperazine compounds as antioxidants
03/17/1999EP0901466A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
03/17/1999EP0901464A1 Hydroxamic acid based inhibitors of the formation of cd23 and tnf
03/17/1999EP0901463A1 Glycerolipidic compounds used for the transfer of an active substance into a target cell
03/17/1999EP0901374A1 Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
03/17/1999EP0901373A1 Alpha v Beta 3 ANTAGONISTS
03/17/1999EP0819003A4 A method for the treatment of macular degeneration
03/17/1999EP0789699B1 SPIRO[HETEROCYCLE-IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE]-4'-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
03/17/1999EP0786946B1 Feed for farmed fish, method to provide fish of high quality and use of additional components to prepare said feed
03/17/1999EP0779076A4 Peptide, a method of obtaining it and a pharmaceutical compound based on it
03/17/1999EP0737070A4 Vitamin d 3? analogues and pathway to mediate disorders
03/17/1999EP0724591B1 Delta 16 unsaturated c 17 heterocyclic steroids useful as steroid c 17-20 lyase inhibitors
03/17/1999EP0678087B1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
03/17/1999EP0637245B1 Preparations of low molecular weight hyaluronic acid for stimulating bone formation
03/17/1999EP0616536B1 Use of decorin or biglycan for the manufacture of a medicament in the treatment of diabetes-associated pathology
03/17/1999EP0565634B1 Angiotensin ii receptor blocking compositions
03/17/1999CN1211256A 17-beta-cyclopropyl (amino/oxy 4-aza steroids as active inhibitors of testosterone 5-alpha-reductase and C17-20-lyase
03/17/1999CN1211251A 1,4-dihydropyridine compounds as bradykinin antagonists
03/17/1999CN1211247A Novel substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211246A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases
03/17/1999CN1211238A Benzimidazole derivatives
03/17/1999CN1210859A New benzimidazole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them
03/17/1999CN1042539C 11,21-bisphenyl-19-norpregnane derivatives
03/17/1999CN1042534C Aroyl urea derivatives or preparing method for additive salts of medicinal acid
03/17/1999CN1042531C Method for preparing corbostyril derivatives
03/16/1999US5883251 Enzyme inhibitors
03/16/1999US5883246 Synthesis of polypyrrolic macrocycles from meso-substituted tripyrrane compounds
03/16/1999US5883239 aroA
03/16/1999US5883129 Hydroxylated anthranilic acid derivatives
03/16/1999US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors
03/16/1999US5883122 Neuroprotective agents
03/16/1999US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/16/1999US5883114 Indolocarbazole imides and the use thereof
03/16/1999US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis
03/16/1999US5883111 Heterocyclic compounds and their use as angiotensin antagonists
03/16/1999US5883099 Treatment of athersclerosis, pancreatitis obesity or hyperglycemia
03/16/1999US5883074 Potentiators of antibacterial agents
03/16/1999US5882910 Lipid kinase
03/16/1999US5882897 yitJ
03/16/1999US5882885 Polypeptides and polynucleotides
03/16/1999US5882671 Using an agonist which acts at negatively coupled camp-linked metabotropic glutamate receptors
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
1 ... 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 ... 1564